Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25912072 | 0.92 | TMPRSS2 (0.33) | TMPRSS2 | |
| SCHEMBL25912077 | 0.92 | TMPRSS2 (0.33) | TMPRSS2 | |
| SCHEMBL25912422 | 0.91 | TMPRSS2 (0.40) | TMPRSS2NPC1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL25912058 | 0.89 | TMPRSS2 (0.35) | TMPRSS2NPC1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL25912086 | 0.87 | TMPRSS2 (0.33) | TMPRSS2 | |
| SCHEMBL25913461 | 0.81 | TMPRSS2 (0.34) | TMPRSS2 | |
| SCHEMBL26320604 | 0.80 | PIK3CD (0.31) | — | |
| SCHEMBL26399308 | 0.80 | PIK3CD (0.31) | — | |
| SCHEMBL25914093 | 0.80 | TMPRSS2 (0.34) | TMPRSS2 | |
| SCHEMBL25914175 | 0.80 | TMPRSS2 (0.36) | TMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022265964-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | VenatoRx Pharmaceuticals, Inc. (US) | 2022-12-22 | — | — | WO | disclosed |